12:00 AM
 | 
Mar 04, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Invitrogen Corp.

(IVGN), San Diego, Calif.

Business: Supply/Service

Merrill Lynch Paul Kelly lowered his intermediate-term rating to "neutral"...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >